Elevance Health Inc.
ELVLast close · Oct 16, 2026428.26−0.17 (−0.04%)
Market cap$92.9B
19 firms' latest targets, last 12 months: median $450.00 ($391.00–$498.00), 5% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | Guggenheim | $460.00 | ▲ 1% | +7% |
| 2026-10-07 | Barclays | $469.00 | ▲ 3% | +10% |
| 2026-07-17 | Leerink Partners | $395.00 | ▲ 9% | -8% |
| 2026-07-16 | Bernstein | $488.00 | ▲ 1% | +14% |
| 2026-07-16 | New Street | $482.00 | — | +13% |
| 2026-07-16 | RBC Capital | $424.00 | ▼ 3% | -1% |
| 2026-07-16 | Goldman Sachs | $395.00 | — | -8% |
| 2026-07-16 | Baird | $393.00 | ▲ 19% | -8% |
| 2026-07-16 | Wells Fargo | $473.00 | ▼ 4% | +10% |
| 2026-07-14 | Truist | $475.00 | ▲ 6% | +11% |
| 2026-07-07 | Raymond James | $450.00 | — | +5% |
| 2026-06-08 | Mizuho Securities | $465.00 | ▲ 7% | +9% |
| 2026-06-04 | Morgan Stanley | $404.00 | ▲ 15% | -6% |
| 2026-05-22 | UBS | $460.00 | ▲ 15% | +7% |
| 2026-05-20 | Deutsche Bank | $498.00 | ▲ 50% | +16% |
| 2026-04-20 | Jefferies | $391.00 | — | -9% |
| 2026-02-02 | Piper Sandler | $409.00 | — | -4% |
| 2026-02-02 | Craig-Hallum | $409.00 | — | -4% |
| 2026-01-08 | Wolfe Research | $425.00 | — | -1% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $171.3B | +9% | $25.22 | +2% | est. $170.4B+1% | est. $33.07 | 14 |
| 2024reported | $177.0B | +3% | $25.68 | +2% | est. $175.8B+1% | est. $33.21 | 15 |
| 2025reported | $199.1B | +12% | $25.21 | -2% | est. $198.6B+0% | est. $29.99 | 16 |
| 2026 | $197.1B | -1% | $27.24 | -9% | $191.7B–$201.7B | $27.02–$28.22 | 13 |
| 2027 | $201.4B | +2% | $29.63 | +9% | $194.1B–$213.9B | $29.01–$30.51 | 13 |
| 2028 | $211.9B | +5% | $33.99 | +15% | $198.9B–$220.7B | $32.14–$36.63 | 9 |
| 2029 | $213.1B | +1% | $39.97 | +18% | $205.9B–$220.5B | $38.20–$41.78 | 4 |
| 2030 | $230.6B | +8% | $46.69 | +17% | $222.7B–$238.6B | $44.63–$48.81 | 4 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.